Company: TAK
Filing Date: 2025-07-02
Form Type: 6-K
Source: 0001395064-25-000111
Chunk: 0

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-07-02
Form: 6-K
Chunk 0
---
#### FORM 6-K

#### U.S. SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

#### Report of Foreign Private Issuer

#### Pursuant to Rule 13a-16 or 15d-16 of

#### the Securities Exchange Act of 1934

#### For the month of July 2025
<div align='center'>Commission File Number:</div>

#### 001-38757

#### Takeda Pharmaceutical Company Limited
<div align='center'>(Translation of registrant’s name into English)</div>

#### 1-1, Nihonbashi Honcho 2-chome

#### Chuo-ku, Tokyo 103-8668

#### Japan
<div align='center'>(Address of principal executive offices)</div>

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

<div align='center'>Form 20-F X Form 40-F</div>

Information furnished on this form:

### EXHIBIT
Exhibit Number

| 4.5 |     | Indenture, dated as of July 2, 2025, among Takeda Pharmaceutical Company Limited, as guarantor, Takeda U.S. Financing, Inc., as issuer, The Bank of New York Mellon, as Trustee, The Bank of New York Mellon, London Branch, as London Paying Agent, and The Bank of New York Mellon SA/SV, Dublin Branch, as Registrar. |
|:----|:----|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.6 |     | Form of $1,650,000,000 5.200% Guaranteed Notes due 2035                                                                                                                                                                                                                                                                  |
| 4.7 |     | Form of $750,000,000 5.900% Guaranteed Notes due 2055                                                                                                                                                                                                                                                                    |
| 5.3 |     | Opinion of Sullivan & Cromwell LLP regarding $1,650,000,000 5.200% Senior Notes due 2035 and $750,000,000 5.900% Guaranteed Notes due 2055                                                                                                                                                                               |
| 5.4 |     | Opinion of Nishimura & Asahi (Gaikokuho Kyodo Jigyo) regarding $1,650,000,000 5.200% Guaranteed Notes due 2035 and $750,000,000 5.